SLC25A39 serves as a pivotal regulator of glutathione (GSH) transport into mitochondria
Primary Analysis CagriSema 2.4mg: 23.0% mean weight loss Zepbound 15mg: 25.5% mean weight loss Treatment Regimen Estimand (Real-World Effectiveness) CagriSema: 20.2% weight loss Zepbound: 23.6% weight loss Because CagriSema did not demonstrate non-inferiority, the trials primary endpoint was not met
Durante el perodo de mantenimiento, se presentaron nuseas, vmitos o diarrea en 14 % de los participantes que continuaron con la dosis mxima tolerada de tirzepatida, en 7 % de los que redujeron la dosis a 5 mg y en 3 % de los que pasaron a recibir placebo
Well use that as our anti nausea agent we do ten weeks on, two to four weeks off
Wilson JM, Lin Y, Luo MJ, Considine G, Cox AL, Bowsman LM, et al
Monthly costs without coverage run approximately $300 to $400 CAD for Ozempic depending on pharmacy and dose